ASH Research Collaborative Press Releases
New research presented at the 2025 American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, Florida, finds that iron overload is a prevalent problem for individuals receiving blood transfusions to treat their sickle cell disease.
ASH Research Collaborative study finds that only one-quarter of patients living with SCD are prescribed a DMT
The ASH Research Collaborative (ASH RC) and the Reagan-Udall Foundation for the Food and Drug Administration (FDA Foundation) are launching the Real-World Evidence Consortium for Sickle Cell Disease (SCD) to develop consensus recommendations on clinical outcomes important to treating people with SCD and apply those standards to real-world data sets.
Grant of $400,000 to help expand sickle cell disease real-world data gathering in the U.S.
The ASH Research Collaborative (ASH RC) has announced the first 10 clinical research consortia to join the ASH RC Sickle Cell Disease Clinical Trials Network.
The ASH Research Collaborative and International Society on Thrombosis and Haemostasis Define Thrombosis-Related Endpoints to Inform COVID-19 Clinical Trial Design.
A study of 656 people with various types of blood cancers who also had COVID-19 infection found that one out of five had died between April and November, based on an analysis of data from the ASH Research Collaborative COVID-19 Registry for Hematology.
Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action.
The American Society of Hematology and ASH Research Collaborative stand in unity with the Council of Medicine Specialty Societies (CMSS) and the 800,000 physicians across 45 medical specialties that deplore the negative impact of racism in our nation and of racial inequities in our healthcare system.
The ASH Research Collaborative (ASH RC) COVID-19 Registry for Hematologic Malignancy has reached the critical milestone of surpassing its first 100 clinical cases submitted.
